Seagen (SGEN) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for SGEN stock
Seagen Inc. Analysis
SGEN Stock News


Popular stocks:
Suncor Energy
Square
Tilray
GameStop
QUALCOMM
Indonesia Energy Corporation

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Wix.com
AeroVironment
Baidu
Brookfield Asset Management
Post Holdings Partnering
Cyngn
The Bank of Nova Scotia
First Horizon
Visionary Education Technology Holdings Group
StoneCo


Financial News

Popular Stocks Analysis

Helpful Highlights
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. SGEN

Seagen (SGEN) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 18, 2024 (12:12)

Sector: Healthcare

The share price of Seagen Inc. (SGEN) now

This company is DELISTED
Latest session on the 9th of January for
Seagen Inc. is negative
Trading Volume: 86
Open: 228.74 /  High: 228.74 /  Low: 228.74
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Seagen stocks, the 50-day moving average is the support level today.

For Seagen stocks, the 200-day moving average is the support level today.

Are you interested in Seagen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Seagen stock price in 2024, 2025, 2026, 2027, 2028. How much will one Seagen share be worth in 2024 - 2028?

When should I take profit in Seagen stock? When should I record a loss on Seagen stock? What are analysts' forecasts for Seagen stock? What is the future of Seagen stock? We forecast Seagen stock performance using neural networks based on historical data on Seagen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Seagen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Seagen shares. This happens once a day.


Historical and forecast chart of Seagen stock

The chart below shows the historical price of Seagen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Seagen stock price can be found in the table below.

No data

Long-term forecasts by years.

Seagen Inc., a biotechnology company, develops and markets cancer treatments in the US and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin’s lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting nectin-4 for the treatment of metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer.

Seagen daily forecast for a month

Date Target Pes. Opt. Vol., %
May 20 232.15 228.76 235.17 2.80
May 21 232.76 230.06 233.78 1.62
May 22 234.81 232.27 235.93 1.58
May 23 234.76 231.47 235.79 1.87
May 24 237.06 234.50 238.72 1.80
May 25 240.57 238.31 244.22 2.48
May 26 239.51 236.16 241.23 2.15
May 27 240.80 237.38 241.77 1.85
May 28 241.53 237.81 243.84 2.54
May 29 238.68 235.00 240.87 2.50
May 30 238.53 235.24 241.63 2.72
May 31 241.87 240.32 243.47 1.31
Jun 01 241.53 238.15 242.79 1.95
Jun 02 243.22 241.96 244.98 1.25
Jun 03 245.46 242.66 246.98 1.78
Jun 04 246.49 244.27 247.97 1.51
Jun 05 246.84 244.47 249.40 2.02
Jun 06 247.68 244.80 250.60 2.37
Jun 07 247.08 245.95 248.42 1.00
Jun 08 243.47 240.50 246.01 2.29
Jun 09 244.94 243.47 248.56 2.09
Jun 10 241.46 237.98 243.78 2.44
Jun 11 245.42 242.13 247.33 2.15
Jun 12 247.63 245.89 250.20 1.75
Jun 13 251.34 248.43 255.21 2.73
Jun 14 254.86 251.09 257.92 2.72
Jun 15 255.32 252.05 257.41 2.13
Jun 16 256.75 255.67 258.75 1.21
Jun 17 257.62 255.51 259.68 1.63
Jun 18 254.27 253.05 256.10 1.21

Seagen Daily Price Targets


Seagen Stock Forecast 05-20-2024.

Forecast target price for 05-20-2024: $232.15.
Positive dynamics for Seagen shares will prevail with possible volatility of 2.725%.
Pessimistic target level: 228.76
Optimistic target level: 235.17

Seagen Stock Forecast 05-21-2024.

Forecast target price for 05-21-2024: $232.76.
Positive dynamics for Seagen shares will prevail with possible volatility of 1.593%.
Pessimistic target level: 230.06
Optimistic target level: 233.78

Seagen Stock Forecast 05-22-2024.

Forecast target price for 05-22-2024: $234.81.
Positive dynamics for Seagen shares will prevail with possible volatility of 1.553%.
Pessimistic target level: 232.27
Optimistic target level: 235.93

Seagen Stock Forecast 05-23-2024.

Forecast target price for 05-23-2024: $234.76.
Negative dynamics for Seagen shares will prevail with possible volatility of 1.832%.
Pessimistic target level: 231.47
Optimistic target level: 235.79

Seagen Stock Forecast 05-24-2024.

Forecast target price for 05-24-2024: $237.06.
Positive dynamics for Seagen shares will prevail with possible volatility of 1.768%.
Pessimistic target level: 234.50
Optimistic target level: 238.72

Seagen Stock Forecast 05-25-2024.

Forecast target price for 05-25-2024: $240.57.
Positive dynamics for Seagen shares will prevail with possible volatility of 2.423%.
Pessimistic target level: 238.31
Optimistic target level: 244.22

SGEN (SGEN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 224.90 219.86 236.77 7.14
Jul. 230.66 217.00 243.02 10.71
Aug. 225.86 213.75 239.95 10.92
Sep. 217.18 208.84 224.13 6.82
Oct. 222.40 208.34 233.96 10.95
Nov. 236.27 223.99 244.40 8.35
Dec. 236.84 228.13 245.18 6.96
Full forecast for 2024

Seagen forecast for this year


Seagen Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $224.897. Pessimistic: $219.86. Optimistic: $236.77


Seagen Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $230.655. Pessimistic: $217.00. Optimistic: $243.02


Seagen Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $225.857. Pessimistic: $213.75. Optimistic: $239.95


Seagen Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $217.184. Pessimistic: $208.84. Optimistic: $224.13


Seagen Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $222.396. Pessimistic: $208.34. Optimistic: $233.96


Seagen Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $236.274. Pessimistic: $223.99. Optimistic: $244.40


Seagen Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $236.841. Pessimistic: $228.13. Optimistic: $245.18



Seagen (SGEN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 237.41 226.20 243.87 7.24
Feb 237.03 231.53 241.20 4.01
Mar 234.94 230.81 247.16 6.62
Apr 230.62 217.71 242.06 10.06
May 217.34 213.34 221.51 3.69
Jun 209.86 204.15 217.08 5.96
Jul 224.80 215.45 232.18 7.20
Aug 236.13 223.85 250.49 10.63
Sep 252.19 242.10 267.93 9.64
Oct 244.32 235.33 256.44 8.23
Nov 257.81 245.02 262.96 6.82
Dec 253.48 242.32 258.34 6.20
Full forecast for 2025

Seagen (SGEN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 247.19 235.52 254.31 7.39
Feb 229.99 225.57 238.82 5.55
Mar 236.79 226.19 248.54 8.99
Apr 240.39 229.05 248.86 7.96
May 250.01 240.61 255.21 5.72
Jun 241.61 233.10 250.50 6.94
Jul 238.52 230.12 245.58 6.29
Aug 254.35 240.31 262.49 8.45
Sep 259.03 249.29 272.71 8.59
Oct 238.52 233.56 242.33 3.62
Nov 242.53 237.48 254.75 6.78
Dec 251.26 239.80 263.72 9.07
Full forecast for 2026

Seagen (SGEN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 265.93 257.42 271.25 5.10
Feb 277.21 265.67 291.18 8.76
Mar 279.87 262.85 293.97 10.59
Apr 294.87 279.06 312.09 10.58
May 296.28 290.12 307.66 5.70
Jun 315.01 298.63 320.05 6.69
Jul 338.95 329.19 360.10 8.58
Aug 356.30 334.92 370.84 9.68
Sep 357.44 348.29 364.88 4.55
Oct 332.56 319.00 348.79 8.54
Nov 343.74 333.29 355.56 6.26
Dec 335.76 316.96 354.57 10.61
Full forecast for 2027

Seagen (SGEN) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 334.69 321.03 353.70 9.24
Feb 332.82 317.91 353.85 10.16
Mar 332.28 311.02 353.28 11.96
Apr 344.78 338.43 351.95 3.84
May 348.91 331.61 357.57 7.26
Jun 358.96 342.88 365.85 6.28
Jul 376.48 362.93 387.02 6.23
Aug 376.78 367.74 389.44 5.57
Sep 352.37 339.96 368.15 7.66
Oct 350.96 341.13 359.38 5.08
Nov 336.08 325.59 353.55 7.91
Dec 341.45 334.08 346.92 3.70
Full forecast for 2028

Seagen information and performance

Seagen Address

N/A

Market Capitalization: N/A $

Market capitalization of the Seagen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of SGEN shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Seagen is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

Align Technology, Inc. (ALGN)
Walgreens Boots Alliance, Inc. (WBA)
Palatin Technologies, Inc. (PTN)
HOOKIPA Pharma Inc. (HOOK)
Kiniksa Pharmaceuticals, Ltd. (KNSA)
Novavax, Inc. (NVAX)
Absci Corporation (ABSI)
Charles River Laboratories International, Inc. (CRL)
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Veeva Systems Inc. (VEEV)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website